New approaches to the issue of pyrogens in parenteral preparations

Czech version

Authors: Michal Janů
Authors‘ workplace: Nemocniční lékárna, Všeobecná fakultní nemocnice v Praze
Published in: Čes. slov. Farm., 2024; 73, 169-174
Category: Pharmaceutical Technology
doi: https://doi.org/10.36290/csf.2024.026

Overview

The article provides a basic understanding of the pathophysiology of exogenous and endogenous pyrogens, particularly in the context of parenteral administration of drugs and the use of medical devices. It explains that pyrogens cause an increase in body temperature by activating the thermoregulatory center in the hypothalamus, with bacterial lipopolysaccharides being the most common source of pyrogenic burden. Contamination of pharmaceuticals with pyrogenic substances can lead to adverse effects, including life-threatening conditions. The text focuses on modern methods for identifying pyrogens, specifically endotoxins, and selecting suitable analytical procedures for their determination. These include in vivo tests on rabbits and the bacterial endotoxin tests, as well as in vitro tests such as the monocyte activation test and the recombinant Factor C test. The work includes a detailed description how to perform these tests, their advantages and disadvantages, and the development of methods for detecting pyrogens in pharmaceuticals. The author explains the reasons of false positive and negative test results, and ilusrates the calculations of threshold endotoxin limits. Information is provided on the new strategy of the European and Czech Pharmacopoeias on this issue, emphasizing efforts to reduce pyrogenic burden and the need to control both microbiological and endotoxin contamination levels.

Keywords:

testing – Endotoxins – pyrogens – limits.

Sources

1. Zámečník J. Patologie. Praha: LD Prager Publishing, 2019. ISBN 978-80-270-6457-1

2. Combes RD. Comprehensive Medicinal Chemistry II, 1.12 – Alternatives to Animal Testing, 2007;1:463-487.

3. Silva CC, et al. Applicability of the Monocyte Activation Test (MAT) for hyperimmune sera in the routine of the quality control laboratory: Comparison with the Rabbit Pyrogen Test (RPT). Toxicology in Vitro 32 (2016):70-75.

4. Komárek P, Rabišková M, et al. Technologie léků. Praha: Galén; 2006:252-253.

5. Bacterial Endotoxins/Pyrogens [online]. FDA, [cit. 11/04/2024]. Available from https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-technical-guides/bacterial-endotoxinspyrogens.

6. Český lékopis 2017. Článek 2. 6. Biologické zkoušky 2. 6. 8. Pyrogenní látky. Praha: Grada; 2017: 254.

7. Československý lékopis, vydání druhé. ČsL 2. Praha Státní zdravotnické nakladatelství: Praha; 1954: 137-138.

8. Vítková E. Metody detekce pyrogenních látek. Vnitřní sdělení SUKL. Praha; 28. 1. 2020.

9. Pyrogen testing with the Monocyte Activation Test | Lonza [online]. [cit. 11/04/2024]. Available from https://bioscience.lonza.com/lonza_bs/CH/en/sustainable-pyrogen-testing-with-the-pyrocell-monocyte-activation-test.

10. The History of Limulus and Endotoxin [Internet]. Marine Biological Laboratory. Archived from the original on 28 October 2008. [cit. 11/04/2024]. Available from http://www.mbl.edu/marine_org/images/animals/Limulus/blood/bang.html.

11. Guidance for Industry: Pyrogen and Endotoxins Testing: Questions and Answers [online]. U.S. Food and Drug Administration. Retrieved 5 March 2019 [cit. 11/04/2024]. Available from Guidance for Industry: Pyrogen and Endotoxins Testing: Questions and Answers | FDA

Další literatura u autora
nebo na webu www.csfarmacie.cz

12. European Directorate for the Quality of Medicines & HealthCare (EDQM). Guidelines for Using the Test for Bacterial Endotoxins. PA/PH/Exp. BET/T (22) 2 COM, European Pharmacopoeia Commission, 2022.

13. Bacterial Endotoxin Test using LAL: overcoming interfering factors [online]. [cit. 11/04/2024]. Available from https://www.europeanpharmaceuticalreview.com/article/161082/bacterial-endotoxin-test-using-lal-methodology-overcoming-interfering-factors/

14. 86-bacterial-endotoxins-tests-using-recombinant-reagents.pdf [online]. [cit. 11/04/2024]. Available from https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/usp-nf-notices/86-bacterial-endotoxins-tests-using-recombinant-reagents.pdf

15. Janů M. Nové přístupy k problematice pyrogenů (endotoxinů). 26. kongres nemocniční farmacie. Ostrava; 11.–13. 11. 2022.

16. Emanuelle Ch. Pyrogenicity strategy. European Pharmacopoeia Department EDQM, Council of Europe, The European directorate for the quality of medicines & healthcare (EDQM), EDQM newsletter, 2022.

17. Kohoutová, I. Pyrogenicity/pyrogenita. Vnitřní sdělení SUKL. Praha; 2. 11. 2022.

18. Wills V. LAL Seminář v ČR. Co je nového v BET světě a opakování je matka moudrosti. Biogenix. Seminář. Bílovice; 16.-17.4 2015.